CHILDREN'S ALLEGRA ODT OTC
Generic Name and Formulations:
Fexofenadine HCl 30mg; orally-disintegrating tabs; orange cream flavor; contains sodium 5mg and phenylalanine 5.3mg per tab.
Indications for CHILDREN'S ALLEGRA ODT:
Allergic rhinitis (seasonal). Chronic idiopathic urticaria.
Place tab on tongue and allow to disintegrate with or without water. 2 tabs every 12 hours; max 4 tabs/24hrs.
<6yrs: not recommended. ≥6yrs: Place tab on tongue and allow to disintegrate with or without water. 1 tab every 12 hours; max 2 tabs/24hrs.
Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant aluminum- or magnesium-containing antacids.
Adults: Headache, back pain, viral infection, GI upset, sinusitis, dizziness, drowsiness. Children: cough, fever, pain, otitis media, upper respiratory tract infection.
Tabs—6; ODT—6; Susp—4oz
Neurology Advisor Articles
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Gender Differences in the Epidemiology of Migraine
- Changes in Glucose Regulation in Parkinson Disease
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Associations Identified Between Stroke Severity, Recovery of Visuospatial Neglect
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Characteristics Affecting Health-Related Quality of Life in RRMS, Progressive MS
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd